论文部分内容阅读
对１９７９年至１９９１年底手术切除的７８８例ＩＩａ期非小细胞肺癌（ＮＳＣＬＣ）的治疗结果进行分析。同时，将全组中３１６例综合治疗与４７２例单纯手术病例进行对比。全组５年生存率１５．３％，其中综合治疗组２３．０％，单纯手术组１０．０％。综合治疗组５年生存率中鳞癌占２６．６％，腺癌２２．８％；单纯手术组５年生存率中鳞癌占１４．１％，腺癌９．９％。结果显示：综合治疗组生存率高于单纯手术组。因此，综合治疗应成为ＩＩａ期ＮＳＣＬＣ的标准治疗方式，并且根据不同ＴＮＭ、病理类型选择不同治疗组合。
The results of the treatment of 788 stage IIa non-small cell lung cancer (NSCLC) surgically resected from 1979 to the end of 1991 were analyzed. At the same time, 316 cases of comprehensive treatment in the whole group were compared with 472 cases of simple surgery. The 5-year survival rate in the whole group was 15.3%, including 23.0% in the comprehensive treatment group and 10.0% in the simple surgery group. In the comprehensive treatment group, the 5-year survival rate was 26.6% for squamous cell carcinoma and 22.8% for adenocarcinoma; the 5-year survival rate for the simple surgical group was 14.1% for squamous cell carcinoma and 9.9% for adenocarcinoma. The results showed that the survival rate in the comprehensive treatment group was higher than that in the simple surgery group. Therefore, comprehensive treatment should be the standard treatment for stage IIa NSCLC, and choose different treatment combinations according to different TNM and pathological types.